MYC and Metabolomics: Can We Use What We Know for DLBCL Subtyping and Diagnosis?
{{output}}
Diffuse large B-cell lymphoma (DLBCL) is a molecular and clinical heterogenous entity, and, over the past 30 years, many efforts have been made in trying to dissect this diverseness and identify biomarkers capable of efficiently stratifying DLBCL patients and ... ...
